HRT FINANCIAL LP sold $100K of SHPH
HRT FINANCIAL LP sold 29,111 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $3.45 ($3.33–$3.52, $0.10M total) across 2 trades over 2026-07-07 to 2026-07-08.
How this was made
The 30-second read
Why it matters
A large 10% owner’s open-market sale may slightly pressure sentiment, especially if investors interpret it as reduced confidence, but it is not accompanied by new guidance, trial results, or corporate actions.
Market read
Traders may monitor SHPH for any follow-on selling pressure or for stabilization after the disclosed sale window.
What to watch
The article does not state whether proceeds were for diversification, taxes, or other obligations, and it does not provide any concurrent company news.
Background
The article is a primary-source SEC Form 4 insider transaction disclosure for Shuttle Pharmaceuticals Holdings, Inc.
Ticker impact
HRT Financial LP, a 10% owner, sold 29,111 Shuttle Pharmaceuticals shares in open-market trades at $3.33 to $3.52.
Likely limited, with any impact more sentiment-driven than fundamental; watch for follow-on selling or stabilization after the sale window.
The filing is a Form 4 open-market sale with no 10b5-1 plan stated, but the article provides no new operational or financial developments beyond the transaction details.
Market effects
No direct sector read-across; this is company-specific insider selling disclosure.
None indicated.
None indicated.
Counterpoint
The sale could be routine liquidity management by a large holder rather than a negative signal about Shuttle Pharmaceuticals prospects.
Key entities
- issuerShuttle Pharmaceuticals Holdings, Inc.
Subject of the Form 4 insider transaction; ticker SHPH.
- 10% ownerHRT Financial LP
Reported open-market sale of 29,111 shares across two trades.